Tilray Italia
About Tilray Italia
Italian subsidiary of Canadian LP Tilray, supplying GMP-grade medical cannabis products to Italian pharmacies through the national health system.
Key Facts
- 1One of the first international LPs authorised to supply medical cannabis to Italy's SSN health system
- 2Products dispensed through hospital and community pharmacies with a medical prescription
Latest News
Cannabis Stocks Rally as DEA Moves Marijuana to Schedule III
AKAN surges alongside TLRY and CGC as federal rescheduling triggers sector-wide momentum with June 2026 hearing set to finalize broader cannabis reclassification.
Major Cannabis Stocks Plunge on Rescheduling Reality Check
TLRY, CGC, ACB, CRON, and OGI tumble as investors reassess limited impact of federal cannabis reclassification on Canadian operators and market fundamentals.
Cannabis Stocks Plunge as Rescheduling Optimism Fades
Major cannabis operators including TLRY, CGC, and ACB tumble as investors reassess limited impact from federal reclassification prospects.
TLRY Stock Plunges 19% as Cannabis Sector Faces Mounting Pressure
Tilray Brands shares tumble amid broader cannabis market selloff, raising questions about sector fundamentals and investor appetite for marijuana stocks.
Cannabis Stocks Whipsaw on Federal Rescheduling Uncertainty
TLRY and cannabis equities experience volatile trading as investors parse mixed signals on federal marijuana policy changes and regulatory timeline.
Frequently Asked Questions
How do patients access Tilray products in Italy?
Patients need a prescription from an authorised physician; products are dispensed at licensed pharmacies.
Is Tilray Italia publicly traded?
The parent company Tilray Brands trades on NASDAQ under TLRY; the Italian subsidiary is not separately listed.
More Cannabis Companies in Rome
Cannabis Laws
Products
- Dried medical cannabis
- Cannabis oil extracts
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Rome, Italy
- Founded
- 2019
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY